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Abstract Several classiﬁcations systems have been developed to predict outcomes of kidney
transplantation based on donor variables.
This study aims to identify kidney transplant recipient variables that would predict graft
outcome irrespective of donor characteristics.
All U.S. kidney transplant recipients between October 25,1999 and January 1, 2007
were reviewed. Cox proportional hazards regression was used to model time until graft
failure. Death-censored and nondeath-censored graft survival models were generated
for recipients of live and deceased donor organs. Recipient age, gender, body mass
index (BMI), presence of cardiac risk factors, peripheral vascular disease, pulmonary
disease, diabetes, cerebrovascular disease, history of malignancy, hepatitis B core
antibody, hepatitis C infection, dialysis status, panel-reactive antibodies (PRA), geo-
graphic region, educational level, and prior kidney transplant were evaluated in all
kidney transplant recipients.
Among the 88,284 adult transplant recipients the following groups had increased risk of
graft failure: younger and older recipients, increasing PRA (hazard ratio [HR],1.03–
1.06], increasing BMI (HR, 1.04–1.62), previous kidney transplant (HR, 1.17–1.26),
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Kidney transplantation represents the best alternative for
survival and improved quality of life for eligible end stage
renal disease patients. Although several classiﬁcations that
estimate outcomes have been developed, they all involve
donor features. The Kidney Donor Risk Index (KDRI) and
Kidney Donor Proﬁle Index (KDPI),1,2 based on deceased
donor age, height, weight, ethnicity, history of hypertension,
history of diabetes, cause of death, serum creatinine, hepatitis
C virus status, and donation after circulatory death, assess the
relative risk of graft failure irrespective of recipient
characteristics.
The objective of this study was to identify kidney trans-
plant recipient variables that would predict graft outcome
irrespective of donor characteristics. These recipient predic-
tive criteria could constitute an instrument of great potential
value and a relevant addition to the current allocation system.
They would provide information on expected outcomes not
only at the time of evaluation and during wait listing when no
donor information is routinely available, but also at the time
of organ allocationwhen theywould be complemented by the
already existing donor classiﬁcations.
Methods
Subjects
Data on 88,284 kidney transplants performed in the United
States from October 25, 1999 to January 1, 2007 obtained
from the United Network for Organ Sharing (UNOS) were
considered in the analysis.
Selection Criteria
There were 119,979 transplants between October 25, 1999
and January 1, 2007. Several variables of interest (drug-
treated hypertension, cerebrovascular disease, and angina)
had collection end dates of January 1, 2007. Since then, they
have become optional data ﬁelds and their reporting has been
sparse. The start date was chosen because relevant donor-
related variables (deceased donor  cardiac arrest post–
brain death), although not of primary interest, had collection
dates beginning October 25, 1999. Recipients listed for pan-
creas (n ¼ 3,629) and kidney pancreas (n ¼ 6,719) as well as
those with no organ listed (n ¼ 16,173) were excluded.
Kidney recipients younger than 18 or with missing age
were also excluded (n ¼ 3,857). There were 1,317 adult
kidney recipients with multiple transplants in our timeframe
of interest. For purposes of our analysis, only the initial
transplant between October 25, 1999 and January 1, 2007
was included. Body mass index (BMI) < 15 or > 55, live
donor preoperative creatinine > 1.5, and deceased donor
terminal creatinine > 6 were deemed unlikely and treated
as unknown.
Primary Outcome Variable
The primary outcome considered was (death-censored and
nondeath-censored) graft survival, as deﬁned in previous
studies.3 In death-censored graft survival, graft survival
was censored at the time of death (based on the assumption
that death was unrelated to the transplant) or at the time of
the last known patient status (if neither failure nor death
occurred). In nondeath-censored graft survival, death with a
functioning graft was treated as graft failure (under the
assumption that death was related to the transplant).
Statistical Analysis
Cox regression was used to model time until graft failure.
Recipient risk factors signiﬁcantly associated with graft fail-
ure using univariable screening at the level of p < 0.10 were
included in the ﬁnal multivariable model. Transplant and
donor variables known to be highly predictive of graft failure,
while not of direct interest, were included in the multivari-
able model as covariates, regardless of statistical signiﬁcance.
Donor variables included human leukocyte antigen (HLA)
mismatch and elements of the KDPI. Although backward
elimination was also considered in building the ﬁnal model,
its results were similar to those of univariable screening and
are not reported here. Separate models were used for recip-
ients of live and deceased donors. Each model was analyzed
using both deﬁnitions of graft survival, resulting in four
multivariable models. The proportional hazards assumption
was evaluated graphically by plotting the log-negative-log of
the estimated survival function by the log of time.
Results
Demographics of the 88,284 subjects included in our ﬁnal
sample are detailed in ►Table 1.
Death-Censored Graft Survival
Recipients of Live Donors
►Table 2 shows the death-censored multivariable Cox re-
gression analysis for graft survival in recipients of live donors
(3,667 graft failures). Younger and older recipients (quadratic
term) had an increased risk of graft failure. Recipients with
overweight or obese BMI, a previous kidney transplant,
hepatitis C, increasing panel-reactive antibodies (PRA), dial-
ysis at the time of transplant, and diabetes also had an
increased risk of graft failure as compared to recipients
dialysis at the time of transplantation (HR, 1.39–1.51), hepatitis C infection (HR, 1.41–
1.63), and educational level (HR, 1.05–1.42).
Predictive criteria based on recipient characteristics could guide organ allocation, risk
stratiﬁcation, and patient expectations in planning kidney transplantation.
International Journal of Angiology Vol. 25 No. 1/2016
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Table 1 Characteristics of kidney transplant recipients of live and deceased donors and all recipients
Factor All recipients
(n ¼ 88,284)
Recipients of live donors
(n ¼ 27,117)
Recipients of deceased
donors (n ¼ 61,167)
Age, y 48.90  13.26 46.03  13.39 50.17  13.00
Gender
Male no. (%) 53,174 (60.23) 16,064 (59.24) 37,110 (60.67)
BMI
Underweight, no. (%) 2,432 (2.75) 775 (2.86) 1,657 (2.71)
Normal weight, no. (%) 31,722 (35.93) 9,954 (36.71) 21,768 (35.59)
Overweight, no. (%) 28,464 (32.24) 8,677 (32.00) 19,787 (32.35)
Obese class I, no. (%) 15,349 (17.39) 4,648 (17.14) 10,701 (17.49)
Obese class II, no. (%) 4,998 (5.66) 1,491 (5.50) 3,507 (5.73)
Obese class III, no. (%) 1,497 (1.70) 476 (1.76) 1,021 (1.67)
Unknown 3,822 (4.33) 1,096 (4.04) 2,726 (4.46)
Previous kidney transplant
Yes 9,467 (10.72) 2,528 (9.32) 6,939 (11.34)
No 78,817 (89.28) 24,589 (90.68) 54,228 (88.66)
Previous malignancy
Yes 3,043 (3.45) 955 (3.52) 2,088 (3.41)
No 74,826 (84.76) 22,995 (84.80) 51,831 (84.74)
Unknown 10,415 (11.80) 3,167 (11.68) 7,428 (11.85)
Angina
Yes 8,684 (9.84) 2,378 (8.77) 6,306 (10.31)
No 74,075 (83.91) 22,922 (84.53) 51,153 (83.63)
Unknown 5,525 (6.26) 1,817 (6.70) 3,708 (6.06)
Drug-treated hypertension
Yes 68,902 (78.05) 21,341 (78.70) 47,561 (77.76)
No 14,887 (16.86) 4,383 (16.16) 10,504 (17.17)
Unknown 4,495 (5.09) 1,393 (5.14) 3,102 (5.07)
Peripheral vascular disease
Yes 2,981 (3.38) 837 (3.09) 2,144 (3.51)
No 79,144 (89.65) 24,368 (89.86) 54,776 (89.55)
Unknown 6,159 (6.98) 1,912 (7.05) 4,247 (6.94)
Drug-treated COPD
Yes 761 (0.86) 217 (0.80) 544 (0.89)
No 82,384 (93.32) 25,341 (93.45) 57,043 (93.26)
Unknown 5,139 (5.82) 1,559 (5.75) 3,580 (5.85)
Symptomatic cerebrovascular disease
Yes 2,046 (2.32) 560 (2.07) 1,486 (2.43)
No 80,551 (91.24) 24,899 (91.82) 55,652 (90.98)
Unknown 5,687 (6.44) 1,658 (6.11) 4,029 (6.59)
Hepatitis B surface antigen
Positive 1,475 (1.67) 395 (1.46) 1,080 (1.77)
Negative 75,098 (85.06) 23,451 (86.48) 51,647 (84.44)
Not done 1,949 (2.21) 562 (2.07) 1,387 (2.27)
Unknown/missing 9,762 (11.06) 2,709 (9.99) 7,053 (11.53)
(Continued)
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without these characteristics. Recipients with a high school
(HS) diploma or general educational development (GED) had
an increased risk of graft failure as compared to attendees of
college, recipients of associate or bachelor’s degrees and
graduate degrees, with hazard ratio (HR) ranging from 1.14
to 1.42. Attendees of college had an increased risk of graft
failure as compared to recipients of associate or bachelor’s
degrees (HR,1.13) and graduate degrees. Recipients in UNOS
transplant region 2 had an increased risk of graft failure as
compared to regions 1, 3, 4, 5, and 10, with HR ranging from
1.20 to 1.27. Malignancy, angina, drug-treated hypertension,
drug-treated chronic obstructive pulmonary disease (COPD),
peripheral vascular disease, and cerebral vascular disease
were not statistically signiﬁcant at p < 0.10 by univariable
screen and were excluded from the ﬁnal multivariable
model.
Table 1 (Continued)
Factor All recipients
(n ¼ 88,284)
Recipients of live donors
(n ¼ 27,117)
Recipients of deceased
donors (n ¼ 61,167)
Hepatitis C status
Positive 4,875 (5.52) 799 (2.95) 4,076 (6.66)
Negative 72,795 (82.46) 23,554 (86.86) 49,241 (80.50)
Not done 6,253 (7.08) 1,592 (5.87) 4,661 (7.62)
Unknown/missing 4,361 (4.94) 1,172 (4.32) 3,189 (5.21)
Dialysis at transplant
Yes 74,094 (83.93) 19,780 (72.94) 54,314 (88.80)
No 12,899 (14.61) 6,839 (25.22) 6,060 (9.91)
Unknown 1,291 (1.46) 498 (1.84) 793 (1.30)
Diabetes at registration
Yes 25,270 (28.62) 7,144 (26.35) 18,126 (29.63)
No 61,130 (69.24) 19,434 (71.67) 41,696 (68.17)
Unknown 1,884 (2.13) 539 (1.99) 1,345 (2.20)
Current PRA (median [Q1, Q3]) 0.0 (0.0, 0.0) 0.00 (0.00, 3.00)
Education
No high school diploma or GED 4,765 (5.40) 994 (3.67) 3,771 (6.17)
High school diploma or GED 33,091 (37.48) 9,114 (33.61) 23,977 (39.20)
Attended college/technical school 17,389 (19.70) 5,951 (21.95) 11,438 (18.70)
Associate/bachelor’s degree 10,811 (12.25) 4,176 (15.40) 6,635 (10.85)
Graduate degree 4,291 (4.86) 1,831 (6.75) 2,460 (4.02)
Unknown/missing 17,937 (20.32) 5,051 (18.63) 12,886 (21.07)
Region
1 3,722 (4.22) 1,202 (4.43) 2,520 (4.12)
2 13,544 (15.34) 4,472 (16.49) 9,072 (14.83)
3 11,145 (12.62) 2,512 (9.26) 8,633 (14.11)
4 7,443 (8.43) 1,865 (6.88) 5,578 (9.12)
5 14,055 (15.92) 4,976 (18.35) 9,079 (14.84)
6 2,960 (3.35) 628 (2.32) 2,332 (3.81)
7 9,398 (10.65) 3,757 (13.85) 5,641 (9.22)
8 4,944 (5.60) 1,463 (5.40) 3,481 (5.69)
9 5,579 (6.32) 1,819 (6.71) 3,760 (6.15)
10 7,567 (8.57) 2,371 (8.74) 5,196 (8.49)
11 7,927 (8.98) 2,052 (7.57) 5,875 (9.60)
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; GED, general educational development; PRA, panel-reactive
antibodies.
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Table 2 Death-censored graft survival in recipients of live donors and recipients of deceased donors
Factora Recipients of live donorsb,c
HR (95% CI)
n ¼ 27,117
Recipients of deceased donorsd,e
HR (95% CI)
n ¼ 61,167
Age 0.93 (0.92, 0.95) 0.94 (0.93, 0.94)
Age age 1.01 (1.00, 1.01) 1.00 (1.00, 1.01)
Gender
Male 0.97 (0.91, 1.04) 1.07 (1.03, 1.11)
Female Reference Reference
BMI
Underweight 1.05 (0.87, 1.26) 0.95 (0.85, 1.05)
Normal weight Reference Reference
Overweight 1.09 (1.00, 1.18) 1.11 (1.07, 1.16)
Obese class I 1.26 (1.14, 1.39) 1.27 (1.20, 1.33)
Obese class II 1.47 (1.28, 1.68) 1.37 (1.27, 1.47)
Obese class III 1.62 (1.32, 1.99) 1.61 (1.43, 1.82)
Previous kidney transplant
Yes 1.25 (1.13, 1.39) 1.17 (1.11, 1.24)
No Reference Reference
Peripheral vascular disease
Yes 1.13 (1.02, 1.25)
No Reference
Hepatitis C status
Positive 1.56 (1.33, 1.83) 1.44 (1.34, 1.54)
Negative Reference Reference
Not done 0.90 (0.75, 1.08) 1.04 (0.96, 1.13)
Dialysis at transplant
Yes 1.43 (1.31, 1.56) 1.51 (1.41, 1.62)
No Reference Reference
Diabetes
Yes 1.09 (1.00, 1.18) 1.02 (0.98, 1.06)
No Reference
Current PRA (in 10-percentage point increments) 1.06 (1.04, 1.08) 1.04 (1.03, 1.05)
Education
No high school diploma or GED 1.33 (1.04, 1.70) 1.00 (0.89, 1.13)
High school diploma or GED 1.42 (1.20, 1.66) 1.12 (1.01, 1.23)
Attended college/technical school 1.24 (1.05, 1.47) 1.06 (0.96, 1.18)
Associate/bachelor’s degree 1.09 (0.92, 1.31) 1.02 (0.92, 1.14)
Graduate degree Reference Reference
Region
1 1.03 (0.86, 1.23) 1.07 (0.97, 1.19)
2 1.27 (1.11, 1.45) 1.37 (1.28, 1.47)
3 1.06 (0.91, 1.23) 1.12 (1.04, 1.21)
4 1.03 (0.87, 1.21) 1.18 (1.09, 1.28)
5 Reference Reference
6 1.00 (0.78, 1.29) 0.94 (0.84, 1.05)
(Continued)
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Recipients of Deceased Donors
►Table 2 shows the death-censored multivariable Cox re-
gression analysis for graft survival in recipients of deceased
donors (13,361 graft failures). Younger and older recipients
had an increased risk of graft failure. Males, recipients with
overweight or obese BMI, a previous kidney transplant,
peripheral vascular disease, hepatitis C, increasing PRA, and
dialysis at the time of transplant also had an increased risk
of graft failure as compared to recipients without these
characteristics. Recipients with a HS diploma or GED had
an increased risk of graft failure as compared to recipients
without a HS diploma, attendees of college, recipients of
associate or bachelor’s degrees, and graduate degrees, with
HR ranging from 1.05 to 1.12. Region 5 and 6 recipients had
a reduced risk of graft failure as compared to all other
regions, excluding region 8, with HR ranging from 0.68 to
0.90. Region 2 recipients had an increased risk of graft
failure as compared to all other regions, excluding 9 and 11,
with HR ranging from 1.16 to 1.46. Region 9 recipients had
an increased risk of graft failure as compared to regions 1,
3, 5, 6, 7, 8, and 10, with HR ranging from 1.13 to 1.36.
Malignancy, drug-treated hypertension, and drug-treated
COPD were not statistically signiﬁcant at p < 0.10 by uni-
variable screen and were excluded from the ﬁnal multivar-
iable model.
Nondeath-Censored Graft Survival
Recipients of Live Donors
►Table 3 shows the noncensored multivariable Cox regres-
sion graft survival analysis for recipients of live donors (6,026
graft failures, inclusive of recipients who died with function-
ing grafts). Younger and older recipients had an increased risk
of graft failure. Recipients with underweight or obese BMI, a
previous kidney transplant, malignancy, drug-treated COPD,
angina, peripheral vascular disease, cerebral vascular disease,
hepatitis C, increasing PRA, dialysis at the time of transplant,
and diabetes also had an increased risk of graft failure as
compared to recipients without these characteristics. Recip-
ients without a HS diploma or GED had an increased risk of
graft failure as compared to recipients of associate or bach-
elor’s degrees (HR,1.22) and graduate degrees. Recipients
with a HS diploma or GED had an increased risk of graft
failure as compared to attendees of college, recipients of
associate or bachelor’s degrees, and graduate degrees with
HR ranging from 1.11 to 1.36. Attendees of college had an
increased risk of graft failure as compared to recipients of
associate or bachelor’s degrees (HR,1.14) and graduate de-
grees. Gender was not statistically signiﬁcant at p < 0.10 by
univariable screen and was excluded from the ﬁnal multivar-
iable model.
Recipients of Deceased Donors
►Table 3 shows the noncensored multivariable Cox regres-
sion graft survival analysis for recipients of deceased donors
(23,231 graft failures inclusive of patients who died with a
functioning graft). Younger and older recipients had an
increased risk of graft failure. Males and recipients with
overweight or obese BMI, a previous kidney transplant,
malignancy, angina, peripheral vascular disease, hepatitis C,
increasing PRA, dialysis at the time of transplant, and diabetes
also had an increased risk of graft failure as compared to
recipients without these characteristics. Recipients with a HS
diploma or GED had an increased risk of graft failure as
compared to attendees of college, recipients of associate or
bachelor’s degrees and graduate degrees, with HR ranging
from1.06 to 1.15. Attendees of collegehad an increased riskof
graft failure as compared to recipients of associate or bach-
elor’s degrees (HR,1.08) and graduate degrees. Recipients
from regions 5, 6, and 8 had a reduced risk of graft failure
Table 2 (Continued)
Factora Recipients of live donorsb,c
HR (95% CI)
n ¼ 27,117
Recipients of deceased donorsd,e
HR (95% CI)
n ¼ 61,167
7 1.16 (1.02, 1.33) 1.11 (1.02, 1.20)
8 1.17 (0.99, 1.38) 1.05 (0.95, 1.15)
9 1.08 (0.90, 1.29) 1.27 (1.17, 1.39)
10 1.06 (0.91, 1.23) 1.13 (1.04, 1.22)
11 1.15 (0.99, 1.33) 1.35 (1.26, 1.46)
Abbreviations: BMI, body mass index; CI, conﬁdence interval; COPD, chronic obstructive pulmonary disease; GED, general educational development;
HR, hazard ratio; PRA, panel-reactive antibodies.
aRecipients of live/deceased donors: Unknown or missing categories are not presented in the table since valid inferences cannot be drawn from them.
bRecipients of live donors: Model is also adjusted for recipient hepatitis B surface antigen. However, the results are not displayed due to nonsigniﬁcance
in the multivariable model.
cRecipients of live donors: Model is also adjusted for donor age, donor BMI, donor gender, donor ethnicity, HLA mismatch level, donor preoperative
creatinine, and donor hepatitis C antibody.
dRecipients of deceased donors: Model is also adjusted for recipient angina status, cerebrovascular disease, and hepatitis B surface antigen. However,
the results are not displayed due to nonsigniﬁcance in the multivariable model.
eRecipients of deceased donors: Model is also adjusted for donor age, donor BMI, donor gender, donor ethnicity, HLA mismatch level, donor terminal
laboratory creatinine, donor hepatitis C antibody, donor history of diabetes, donor history of hypertension, donor cause of death, and donor cardiac
arrest postbrain death.
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Table 3 Nondeath-censored graft survival in recipients of live donors and recipients of deceased donors
Factora Recipients of live donorsb,c
HR (95% CI)
n ¼ 27,117
Recipients of deceased donorsd,e
HR (95% CI)
n ¼ 61,167
Age 0.92 (0.91, 0.93) 0.93 (0.93, 0.94)
Age age 1.01 (1.00, 1.01) 1.00 (1.00, 1.01)
Gender
Male 1.12 (1.09, 1.15)
Female Reference
BMI
Underweight 1.19 (1.02, 1.38) 1.07 (0.98, 1.16)
Normal weight Reference Reference
Overweight 1.01 (0.95, 1.08) 1.04 (1.01, 1.07)
Obese class I 1.10 (1.02, 1.38) 1.17 (1.12, 1.21)
Obese class II 1.32 (1.18, 1.47) 1.21 (1.14, 1.28)
Obese class III 1.46 (1.23, 1.73) 1.54 (1.40, 1.69)
Previous kidney transplant
Yes 1.26 (1.15, 1.37) 1.19 (1.14, 1.24)
No Reference Reference
Malignancy
Yes 1.28 (1.13, 1.44) 1.10 (1.03, 1.18)
No Reference Reference
Drug-treated COPD
Yes 1.54 (1.24, 1.92) 1.10 (0.97, 1.25)
No Reference Reference
Angina
Yes 1.11 (1.02, 1.21) 1.18 (1.13, 1.23)
No Reference Reference
Peripheral vascular disease
Yes 1.27 (1.12, 1.43) 1.30 (1.22, 1.38)
No Reference Reference
Cerebral vascular disease
Yes 1.21 (1.04, 1.41) 1.05 (0.97, 1.14)
No Reference Reference
Hepatitis C status
Positive 1.63 (1.44, 1.84) 1.41 (1.33, 1.49)
Negative Reference Reference
Not done 0.95 (0.82, 1.10) 1.02 (0.95, 1.08)
Dialysis at transplant
Yes 1.46 (1.36, 1.56) 1.39 (1.32, 1.46)
No Reference Reference
Diabetes
Yes 1.42 (1.34, 1.50) 1.32 (1.28, 1.36)
No Reference Reference
Current PRA (in 10-percentage point increments) 1.05 (1.04, 1.07) 1.03 (1.03, 1.04)
Education
(Continued)
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compared to all other regions, excluding 1, with HR ranging
from 0.76 to 0.93. Recipients from region 2 had an increased
riskof graft failure compared to regions 1, 3, 5, 6, 7, and 8,with
HR ranging from 1.08 to 1.26. Recipients from region 11 had
an increased riskof graft failure compared to all other regions,
excluding 2, with HR ranging from 1.08 to 1.31. All variables
were statistically signiﬁcant at p < 0.10 by univariable screen
and all were included in the ﬁnal multivariable model.
Discussion
Our series identiﬁed recipient age, increasing PRA, BMI, prior
transplant, dialysis at the time of transplantation, hepatitis C
infection, and education as variables associated with in-
creased risk for graft failure in adult kidney transplant
recipients regardless of survival deﬁnition or donor type.
Younger and elderly recipients had an increased risk of
graft failure. A higher degree of immune responsiveness,
immunosuppressive medication noncompliance, ﬁnancial,
and social factors have been postulated to contribute to a
greater incidence of early graft loss in the young.4–6 Previous
studies reported elderly recipients to have a high incidence of
comorbidities, frailty, and death with functioning grafts, as
well as a greater impact of rejection on graft loss.7
PRA is an immunological test that quantiﬁes the percent-
age of the population against which an individual reacts via
preformed antibodies. Recipients with PRA  80% have a
higher risk of acute rejection leading to graft failure, and
are given additional points in the organ allocation
algorithm.8
BMI is a measure of body fat based on height and weight.9
Patients with BMI  30 (obese classes I, II, and III) had an
increased risk of graft failure when compared with those
with lower BMI. An analysis of adult renal transplant patients
registered in U.S. Renal Data System had demonstrated that
BMI < 18 and > 36 were associated with worse patient and
graft survival.10 Surgical-site infections, delayed graft func-
tion, prolonged hospitalization, acute rejection, and de-
creased overall graft survival had previously been found to
be more prevalent in obese individuals.11,12
Table 3 (Continued)
Factora Recipients of live donorsb,c
HR (95% CI)
n ¼ 27,117
Recipients of deceased donorsd,e
HR (95% CI)
n ¼ 61,167
No high school diploma or GED 1.32 (1.10, 1.57) 1.05 (0.97, 1.15)
High school diploma or GED 1.36 (1.21, 1.53) 1.15 (1.07, 1.23)
Attended college/technical school 1.23 (1.09, 1.39) 1.08 (1.01, 1.17)
Associate/bachelor’s degree 1.08 (0.95, 1.23) 1.00 (0.93, 1.09)
Graduate degree Reference Reference
Region
1 1.04 (0.91, 1.20), 1.07 (0.99, 1.15)
2 1.18 (1.07, 1.31) 1.22 (1.16, 1.29)
3 1.09 (0.97, 1.23) 1.13 (1.07, 1.19)
4 0.98 (0.80, 1.19) 1.16 (1.10, 1.23)
5 Reference Reference
6 0.98 (0.80, 1.19) 0.97 (0.90, 1.06)
7 1.11 (1.00, 1.23) 1.13 (1.06, 1.20)
8 1.09 (0.95, 1.24) 1.05 (0.98, 1.12)
9 1.07 (0.93, 1.23) 1.18 (1.11, 1.26)
10 1.08 (0.97, 1.21) 1.16 (1.10, 1.24)
11 1.20 (1.07, 1.34) 1.27 (1.20, 1.35)
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; CI, conﬁdence interval; GED, general educational development;
HR, hazard ratio; PRA, panel-reactive antibodies.
aRecipients of live/deceased donors: Unknown or missing categories are not presented in the table since valid inferences cannot be drawn from them.
bRecipients of live donors: Model is also adjusted for recipient drug-treated hypertension and hepatitis B surface antigen. However, the results are not
displayed due to nonsigniﬁcance in the multivariable model or signiﬁcance in the unknown category.
cRecipients of live donors: Model is also adjusted for donor age, donor BMI, donor gender, donor ethnicity, HLA mismatch level, donor preoperative
creatinine, and donor hepatitis C antibody.
dRecipients of deceased donors: Model is also adjusted for recipient drug-treated hypertensionand hepatitis B surface antigen. However, the results
are not displayed due to nonsigniﬁcance in the multivariable model or signiﬁcance in the unknown category.
eRecipients of deceased donors: Model is also adjusted for donor age, donor BMI, donor gender, donor ethnicity, HLA mismatch level, donor terminal
laboratory creatinine, donor hepatitis C antibody, donor history of diabetes, donor history of hypertension, donor cause of death, and donor cardiac
arrest postbrain death.
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Prior smaller studies had reported conﬂicting results on
retransplantation outcomes.13–15 In our series retransplan-
tation was associated with decreased graft survival.
The process of dialysis is associated with micro- and
macrovascular pathologies, malnutrition, chronic systemic
inﬂammation, and decreased renal clearance.16 Studies have
shown that patients who are preemptively transplanted have
improved graft survival.17 Longer transplant wait timeswhile
on dialysis negatively impact posttransplant graft function.16
End-stage renal disease and chronic dialysis can be associated
with up to a 72% increase in mortality risk.16
Our study demonstrated that recipientswith a diagnosis of
hepatitis C before transplantation had an increased risk of
graft failure, an observation consistent with prior reports.18
This ﬁnding was consistent in all four models. Chronic active
hepatitis and cirrhosis should be thoroughly evaluated prior
to kidney transplantation.19
Previous studies showed that education could have an
association with improved outcomes.20–22 We observed in-
creased graft survival among HS graduates irrespective of
deﬁnition or donor type.
Prior malignancy, peripheral vascular disease, angina, and
diabeteswere associatedwith an increased riskof graft failure
in recipients of both live and deceased donors only when
using the nondeath-censored deﬁnition (that treats all deaths
as graft failures). This difference could potentially be attrib-
utable to deaths associatedwithmalignancies, cardiovascular
disease, and diabetic complications.23,24 UNOS and the Organ
Procurement and Transplantation Network (OPTN) facilitate
organ procurement, allocation, and transplantation by divid-
ing the nation into 11 regions that loosely correspond to U.S.
census regions.25 Variations in waiting list times, availability
of organs, and transplant rates have been previously re-
ported26 and could account for some of the regional geo-
graphic differences observed.
The timeframe of October 25, 1999 through January 1,
2007 was chosen because some variables of interest had a
collection end date of January 1, 2007. These variables are
currently optional data ﬁelds and become very sparse inmore
recent years. Additionally, important donor-related variables,
while not of primary interest for this study, had collection
dates that began on October 25, 1999. Certain assumptions
were made in regard to plausible values for BMI and creati-
nine. Speciﬁcally, BMI < 15 or > 55, live donor preoperative
creatinine > 1.5 and deceased donor terminal creatinine > 6
were deemed unlikely values due to common donor selection
practices and were interpreted as missing or unknown. Some
important predictors of graft failure were excluded due to
large amounts of missing data, such as warm and cold
ischemia times. With limitations related to quality control,
variableswhichwere found to be nonsigniﬁcantmaynot have
been appropriately registered or followed up over time in the
database and should be considered further in detail. Donor
variables for inclusion in the multivariable model were based
on HLAmismatch and on the KDPI. Since KDPI addresses only
deceased donors, variables such as diabetes, cause of death,
and cardiac arrest postbrain death were not relevant for live
donors.
Conclusions
We propose a model based on the recipient characteristics,
and independent of donor variables. Age, increasing PRA,
BMI, prior transplant, dialysis at the time of transplantation,
hepatitis C infection, and education were found to be associ-
ated with an increased risk for graft failure in adult kidney
transplant recipients regardless of survival deﬁnition and
donor type. These recipient predictive criteria could further
optimize outcomes and organ allocation27 by providing in-
formation not only at the time of evaluation and during wait
listing when no donor information is routinely available, but
also at the time of organ allocation when they would be
complemented by the already existing donor grading
classiﬁcations.
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